Upload File

disclosure statement of financial interest · disclosure statement of financial interest i, c....

  • Home
  • Documents
  • Disclosure Statement of Financial Interest · Disclosure Statement of Financial Interest I, C. Stellingwerf, DO NOT have a financial interest/arrangement or affiliation with one or
44
Disclosure Statement of Financial Interest I, C. Stellingwerf, DO NOT have a financial interest/arrangement or affiliation with one or more organisations which could be perceived as a real or apparent conflict of interest in the context of the subject of this presentation.

Upload: others

Post on 16-Nov-2019

6 views

Category:

Documents


0 download

Report

TRANSCRIPT

Page 1: Disclosure Statement of Financial Interest · Disclosure Statement of Financial Interest I, C. Stellingwerf, DO NOT have a financial interest/arrangement or affiliation with one or

Disclosure Statement of Financial Interest

I, C. Stellingwerf, DO NOT have a financial interest/arrangement or affiliation with one or more organisations which could be perceived as a real or apparent conflict of interest in the context of the subject of this presentation.

Page 2: Disclosure Statement of Financial Interest · Disclosure Statement of Financial Interest I, C. Stellingwerf, DO NOT have a financial interest/arrangement or affiliation with one or

Visuele problematiek in de werkomgeving

Nynke Stellingwerf, Willemien van de Werken Koninklijke Visio, Haren en OMCNoord/Hanzekliniek Groningen April 2017

Page 3: Disclosure Statement of Financial Interest · Disclosure Statement of Financial Interest I, C. Stellingwerf, DO NOT have a financial interest/arrangement or affiliation with one or

Inhoud

Wie zijn wij ICF Veel voorkomende oogaandoeningen op

‘t werk En de functiestoornissen

Van belemmeringen naar mogelijkheden (Adviseur visuele problematiek bij arbeid)

11-5-2017

Page 4: Disclosure Statement of Financial Interest · Disclosure Statement of Financial Interest I, C. Stellingwerf, DO NOT have a financial interest/arrangement or affiliation with one or

ICF..

Page 5: Disclosure Statement of Financial Interest · Disclosure Statement of Financial Interest I, C. Stellingwerf, DO NOT have a financial interest/arrangement or affiliation with one or

Keratoconus, corneadystrofieen

11-5-2017

Page 6: Disclosure Statement of Financial Interest · Disclosure Statement of Financial Interest I, C. Stellingwerf, DO NOT have a financial interest/arrangement or affiliation with one or

Keratoconus

Instabiele refractie Irregulair astigmatisme, myopie Vervorming, lichthinder Geen bril maar harde lenzen Gaat vaak lang goed

Progressie voorkomen met crosslinking Anders corneatransplantatie

11-5-2017

Page 7: Disclosure Statement of Financial Interest · Disclosure Statement of Financial Interest I, C. Stellingwerf, DO NOT have a financial interest/arrangement or affiliation with one or

Cataract

11-5-2017

Page 8: Disclosure Statement of Financial Interest · Disclosure Statement of Financial Interest I, C. Stellingwerf, DO NOT have a financial interest/arrangement or affiliation with one or

Cataract - staar

11-5-2017

Page 9: Disclosure Statement of Financial Interest · Disclosure Statement of Financial Interest I, C. Stellingwerf, DO NOT have a financial interest/arrangement or affiliation with one or

Cataract

Verlaagde visus en contrastzien Verhoogde lichtverstrooiing

Operatie Herstel definitieve bril 4 weken na operatie

Page 10: Disclosure Statement of Financial Interest · Disclosure Statement of Financial Interest I, C. Stellingwerf, DO NOT have a financial interest/arrangement or affiliation with one or

11-5-2017

Page 11: Disclosure Statement of Financial Interest · Disclosure Statement of Financial Interest I, C. Stellingwerf, DO NOT have a financial interest/arrangement or affiliation with one or

Glare - verblinding

11-5-2017

cave

Page 12: Disclosure Statement of Financial Interest · Disclosure Statement of Financial Interest I, C. Stellingwerf, DO NOT have a financial interest/arrangement or affiliation with one or

Glaucoom

11-5-2017

Page 13: Disclosure Statement of Financial Interest · Disclosure Statement of Financial Interest I, C. Stellingwerf, DO NOT have a financial interest/arrangement or affiliation with one or

Glaucoom

Ongemerkt gezichtsveldbeperking: - Filling in Visus blijft lang normaal Afname contrastgevoeligheid

Behandeling vertraagt proces Bij symptomen geen verbetering te

verwachten

Page 14: Disclosure Statement of Financial Interest · Disclosure Statement of Financial Interest I, C. Stellingwerf, DO NOT have a financial interest/arrangement or affiliation with one or

Verlaagde contrastgevoeligheid

11-5-2017

Page 15: Disclosure Statement of Financial Interest · Disclosure Statement of Financial Interest I, C. Stellingwerf, DO NOT have a financial interest/arrangement or affiliation with one or

Filling in

11-5-2017

Page 16: Disclosure Statement of Financial Interest · Disclosure Statement of Financial Interest I, C. Stellingwerf, DO NOT have a financial interest/arrangement or affiliation with one or

Onderdiagnostiek

11-5-2017

Page 17: Disclosure Statement of Financial Interest · Disclosure Statement of Financial Interest I, C. Stellingwerf, DO NOT have a financial interest/arrangement or affiliation with one or

Maculadegeneratie

11-5-2017

Page 18: Disclosure Statement of Financial Interest · Disclosure Statement of Financial Interest I, C. Stellingwerf, DO NOT have a financial interest/arrangement or affiliation with one or

Maculadegeneratie

Verlaagde visus Normaal gezichtsveld (centraal scotoom) Droge MD: geleidelijk achteruitgang

Natte MD: mogelijk stabiel met

maandelijks injectie (anti-Vegf)

11-5-2017

Page 19: Disclosure Statement of Financial Interest · Disclosure Statement of Financial Interest I, C. Stellingwerf, DO NOT have a financial interest/arrangement or affiliation with one or

Metamorfopsie

11-5-2017

Page 20: Disclosure Statement of Financial Interest · Disclosure Statement of Financial Interest I, C. Stellingwerf, DO NOT have a financial interest/arrangement or affiliation with one or

Epiretinale fibrose of “pucker”

11-5-2017

Page 21: Disclosure Statement of Financial Interest · Disclosure Statement of Financial Interest I, C. Stellingwerf, DO NOT have a financial interest/arrangement or affiliation with one or

Serosa

Middelbare leeftijd Mannen Stress Self limiting met rest Evt laserbehandeling

11-5-2017

Page 22: Disclosure Statement of Financial Interest · Disclosure Statement of Financial Interest I, C. Stellingwerf, DO NOT have a financial interest/arrangement or affiliation with one or

Diabetische retinopathie

11-5-2017

Page 23: Disclosure Statement of Financial Interest · Disclosure Statement of Financial Interest I, C. Stellingwerf, DO NOT have a financial interest/arrangement or affiliation with one or

Diabetische retinopathie

Verminderde visus bij oedeem Verminderd gezichtsveld na pan-laser Bij oedeem behandelen met laser en

anti-Vegf (lang traject) Laser heeft gevolgen voor visus en

gezichtsveld, en zicht in het donker

11-5-2017

Page 24: Disclosure Statement of Financial Interest · Disclosure Statement of Financial Interest I, C. Stellingwerf, DO NOT have a financial interest/arrangement or affiliation with one or

11-5-2017

Page 25: Disclosure Statement of Financial Interest · Disclosure Statement of Financial Interest I, C. Stellingwerf, DO NOT have a financial interest/arrangement or affiliation with one or

Retinitis pigmentosa

Zeldzaam, vaak erfelijk, vroege en late vormen Begint met nachtblindheid Daarna gezichtsveldbeperking Visus vaak lang gespaard Progressief en (nog) geen goede

therapie Soms combinatie met slechthorendheid:

Usher

11-5-2017

Page 26: Disclosure Statement of Financial Interest · Disclosure Statement of Financial Interest I, C. Stellingwerf, DO NOT have a financial interest/arrangement or affiliation with one or

Nachtblindheid

11-5-2017

Page 27: Disclosure Statement of Financial Interest · Disclosure Statement of Financial Interest I, C. Stellingwerf, DO NOT have a financial interest/arrangement or affiliation with one or

Floaters en netvliesloslating

11-5-2017

Page 28: Disclosure Statement of Financial Interest · Disclosure Statement of Financial Interest I, C. Stellingwerf, DO NOT have a financial interest/arrangement or affiliation with one or

Netvliesloslating (ablatio retinae)

Acute gezichtsvelduitval Visusverlies als niet snel behandeld

Na operatie gezichtsveld terug Visus niet altijd weer goed Bij operatie met gas weken slechtere

functie (cave vliegen, bergen etc)

11-5-2017

Page 29: Disclosure Statement of Financial Interest · Disclosure Statement of Financial Interest I, C. Stellingwerf, DO NOT have a financial interest/arrangement or affiliation with one or

Floaters (mouches volantes)

Veel voorkomend Meestal onschuldig Wel hinderlijk Soms voorbode van netvliesloslating Ook bij uveitis, bloedingen

Opties: goede refractie Evt laser of vitrectomie

11-5-2017

Page 30: Disclosure Statement of Financial Interest · Disclosure Statement of Financial Interest I, C. Stellingwerf, DO NOT have a financial interest/arrangement or affiliation with one or

Computervisie syndroom

11-5-2017

Page 31: Disclosure Statement of Financial Interest · Disclosure Statement of Financial Interest I, C. Stellingwerf, DO NOT have a financial interest/arrangement or affiliation with one or

Computervisie syndroom

Geirriteerde, pijnlijke ogen Visusklachten (focussen, dubbelzien) Oogoppervlak klachten (waterig, droog,

geirriteerd, contacctlensproblemen) Pijnklachten rug nek schouders

(gedwongen houding multofocale glazen)

11-5-2017

Page 32: Disclosure Statement of Financial Interest · Disclosure Statement of Financial Interest I, C. Stellingwerf, DO NOT have a financial interest/arrangement or affiliation with one or

Droge ogen en blepharitis

11-5-2017

Page 33: Disclosure Statement of Financial Interest · Disclosure Statement of Financial Interest I, C. Stellingwerf, DO NOT have a financial interest/arrangement or affiliation with one or

Oorzaken

Meestal presbyopie (of andere ohk oorzaak) Combinatie met hoge eisen – veel in

dezelfde houding

11-5-2017

Page 34: Disclosure Statement of Financial Interest · Disclosure Statement of Financial Interest I, C. Stellingwerf, DO NOT have a financial interest/arrangement or affiliation with one or

Oplossingen

Leesbril / computerbril monofocaal Bril af Bifocale bril, Trifocale bril Monovision Multifocale IOL of contactlens Kunsttranen

Bewustwording, afwisselen werk/pauze

11-5-2017

Page 35: Disclosure Statement of Financial Interest · Disclosure Statement of Financial Interest I, C. Stellingwerf, DO NOT have a financial interest/arrangement or affiliation with one or

Computerbril

11-5-2017

Page 36: Disclosure Statement of Financial Interest · Disclosure Statement of Financial Interest I, C. Stellingwerf, DO NOT have a financial interest/arrangement or affiliation with one or

Kleurenblindheid

8% van de mannen, aangeboren Soms slechtziend (verworven) Meeste banen weinig problemen Te weinig aandacht websites

11-5-2017

Page 37: Disclosure Statement of Financial Interest · Disclosure Statement of Financial Interest I, C. Stellingwerf, DO NOT have a financial interest/arrangement or affiliation with one or

11-5-2017

Page 38: Disclosure Statement of Financial Interest · Disclosure Statement of Financial Interest I, C. Stellingwerf, DO NOT have a financial interest/arrangement or affiliation with one or

Gezichtsvelduitval door NAH (30%)

11-5-2017

Page 39: Disclosure Statement of Financial Interest · Disclosure Statement of Financial Interest I, C. Stellingwerf, DO NOT have a financial interest/arrangement or affiliation with one or

Visuele klachten NAH (70%)

11-5-2017

Verminderde visus, contrastzien, accommodatie, convergentie Oogbewegingsstoornis Nystagmus Veranderde lichtgevoeligheid (94%!) Zowel meer licht nodig als meer lichthinder Kleuren minder helder (21%) Moeite met dieptezien (21%), stereozien Diplopie (al of niet bij beweging) Visuele illusies en hallucinaties Visuele perceptie stoornissen

Page 40: Disclosure Statement of Financial Interest · Disclosure Statement of Financial Interest I, C. Stellingwerf, DO NOT have a financial interest/arrangement or affiliation with one or

Revalidatie bij Visio

Intakegesprek Onderzoek optometrist (of oogarts, orthoptist, (neuro)psycholoog) Multidisciplinair overleg Advies/ training mobiliteit (incl advies naar CBR), ICT, lezen, psychologische begeleiding, maatschappelijk werk, Groepen voor bv vrije tijd, uitleg omgeving Advies arbeid

11-5-2017

Page 41: Disclosure Statement of Financial Interest · Disclosure Statement of Financial Interest I, C. Stellingwerf, DO NOT have a financial interest/arrangement or affiliation with one or

Leeshulpmiddelen

11-5-2017

Page 42: Disclosure Statement of Financial Interest · Disclosure Statement of Financial Interest I, C. Stellingwerf, DO NOT have a financial interest/arrangement or affiliation with one or

ICT

11-5-2017

Page 43: Disclosure Statement of Financial Interest · Disclosure Statement of Financial Interest I, C. Stellingwerf, DO NOT have a financial interest/arrangement or affiliation with one or

Basisverlichting en taakverlichting

11-5-2017

Page 44: Disclosure Statement of Financial Interest · Disclosure Statement of Financial Interest I, C. Stellingwerf, DO NOT have a financial interest/arrangement or affiliation with one or

Hulpmiddel mobiliteit

11-5-2017


Public Interest Disclosure Policy

Disclosure of finanacial interest * Author has no financial interest in this paper

Financial Interest Disclosure System FIDS Ciara Nic Mhathúna ORIS

Disclosure of Financial Relationships and Resolution of Conflicts … · 2019-11-07 · Disclosure of Financial Relationships and Resolution of Conflicts of Interest for AAP CME Activities

PUBLIC INTEREST DISCLOSURE PROCEDURE 2017

I have a financial interest with the following companies: Abbott Medical Optics Alcon Calhoun Vision NuLens Optimedica Optivue Financial Disclosure

HANDBOOK SUPERVISORY REVIEW OF FINANCIAL DISCLOSURE … · Handbook: Supervisory Review of Financial Disclosure ... A conflict of interest or an appearance of a ... Supervisory Review

Disclosure Statement of Financial Interest I DO NOT have a ... · I DO NOT have a financial conflict of interest in the context of this presentation. Disclosure Statement of Financial

2019 Disclosure of Interest Information

Judge Gerard Adelmans Financial Interest Disclosure Statements

Public Interest Disclosure Act 2013

Public Interest Disclosure Procedures

FINANCIAL DISCLOSURE REPORT - Judicial Watch · FINANCIAL DISCLOSURE REPORT . ... Codc 3 merger, div. rent. or Code2 Code2 Code . ... Div Fin Auth SFM Ser B B Interest K T •·

PUBLIC INTEREST DISCLOSURE PROCEDURE

Electronic Financial Disclosure User Documentation docs... · 2010. 7. 27. · Liaison User Guide (February 2010) CITY OF NEW YORK Conflicts of Interest Board Financial Disclosure

The RIBS IV Clinical Trial - SAC · Disclosure Statement of Financial Interest • None • None Within the past 12 months, I or my spouse/partner have had a financial interest/arrangement

*Financial Interest: The authors have no financial interest in the subject matter of this poster. *Disclosure of Unapproved/Off-Label Use: The use of cholesterol

Conflict of Interest Disclosure

Financial Conflict of Interest Training - Vanderbilt … the reporting of Financial Conflicts of Interest related to: Definitions Investigator Disclosure Responsibilities (e.g., what

Financial Disclosure As it pertains to CME, I have no relevant financial relationships with any commercial interest to disclose. Minimally Invasive Surgery

Westminster Financial Companies Regulation Best Interest … · 2020. 7. 2. · 1 Westminster Financial Companies Regulation Best Interest Disclosure Document Effective June 30, 2020

PUBLIC INTEREST DISCLOSURE (p39p5.pdf

PUBLIC INTEREST DISCLOSURE GUIDELINES

Ancillary Information Conflicts of Interest Disclosure ... · Ancillary information/COI Disclosure Research Project Form Revised July 24, 2017 6. Report the existence of any financial

Conflict of Interest Resolution and Disclosure · Disclosure –Standard 2 (cont.)•SCS 2.2 An individual who refuses to disclose relevant financial relationships will be disqualified

Faculty Disclosure Emily Oken, MD, MPH Dr. Oken has listed no financial interest/arrangement that would be considered a conflict of interest

Financial Disclosure: Authors do not have financial or commercial interest in mentioned equipments Dr Arce is Consultant & Territory Manager for Latin

Public interest disclosure procedure · 1 Public Interest Disclosure Procedure: V1.0 (July 2019) Public interest disclosure Procedure Classification C 1. Purpose 1.1 The objective

Public Disclosure Authorized Transparency, …...perfect competition environment taking the interest rate for deposits and the interest rate for borrowers (investors) as given. Financial

Faculty Disclosure Karla K. Lester, MD Dr. Lester has listed no financial interest/arrangement that would be considered a conflict of interest

Disclosure of finanacial interest * Author has no financial interest in this paper. ** Author's research is partially funded by Imperial Medical Technologies

Financial Disclosure

Faculty Disclosure Amy J. Arouni, MD, FACC Dr. Arouni has listed no financial interest/arrangement that would be considered a conflict of interest

CONFLICTS OF INTEREST, FINANCIAL DISCLOSURE, GIFT LAWS

Developing the Nurse Coordinator Role. Disclosure Statement of Financial Interest I, Janine Carlson, DO NOT have any financial disclosures